Ofloxacin

氧氟沙星

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameOfloxacin
Drug Alias NameOfloxacino氟嗪酸泰利必妥Ofloxacinum氧氟多沙 +[20] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsConjunctivitisOtitis MediaOtitis Externa +[7] 
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryJapan
Original Approved Date1985/04/16
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAllergan PlcLivzon(Group) Pharmaceutical Factory
Inactive CompaniesJanssen Pharmaceuticals IncThe University Of OklahomaDaiichi Sankyo Co Ltd
Active IndicationsConjunctivitisCorneal UlcerBacterial Infections
Inactive IndicationsOtitis MediaOtitis ExternaHearing Loss +[4] 

Other Information

ATC CodeJ01MA01S01AE01S02AA16
Related LinksWikipediaDrugBankKEGG